Investor Relations

Syneron Medical Ltd (ELOS) IR Room

Fundamentals

Select the financial statements you wish to view below.  The reports below may be viewed on either an annual or quarterly basis.

NASDAQELOS
All numbers in thousands USD
Period Ending
12/31/2016
12/31/2015
12/31/2014
12/31/2013
Total Revenue
298,102
277,849
255,750
256,915
Cost of Revenue
142,469
128,884
119,771
126,838
Gross Profit
155,633
148,965
135,979
130,077
Operating Expenses
Research Development
23,043
25,270
24,619
29,996
Selling General and Administrative
124,379
127,224
109,109
110,823
Non Recurring
--
--
--
--
Others
4,983
2,930
4,468
(4,623)
Total Operating Expenses
152,405
155,424
138,196
136,196
Operating Income or Loss
3,228
(6,459)
(2,217)
(6,119)
Income from Continuing Operations
Total Other Income/Expenses Net
0
(389)
(1,249)
0
Earnings Before Interest And Taxes
3,228
(6,459)
(2,837)
(6,119)
Interest Expense
--
--
68
254
Income Before Tax
3,992
(6,292)
(2,905)
(6,093)
Income Tax Expense
3,813
48
2,295
(7,640)
Minority Interest
--
--
--
0
Net Income From Continuing Ops
179
(6,340)
(5,200)
1,547
Non-recurring Events
Discontinued Operations
--
--
--
--
Extraordinary Items
--
--
--
--
Effect Of Accounting Changes
--
--
--
--
Other Items
0
0
0
100
Net Income
179
(6,340)
(5,200)
1,647
Preferred Stock And Other Adjustments
--
--
--
--
Net Income Applicable To Common Shares
179
(6,340)
(5,200)
1,647
NASDAQELOS

print email